National Health Investors, Inc.
NHI
$76.94
$0.12850.17%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 70.27M | 68.87M | 65.78M | 63.32M | 65.76M |
Total Other Revenue | 21.92M | 20.85M | 19.97M | 19.63M | 19.45M |
Total Revenue | 92.19M | 89.71M | 85.76M | 82.94M | 85.21M |
Cost of Revenue | 11.92M | 13.73M | -28.65M | 13.53M | 13.69M |
Gross Profit | 80.27M | 75.99M | 114.41M | 69.41M | 71.52M |
SG&A Expenses | 7.22M | 8.26M | 5.83M | 5.05M | 5.04M |
Depreciation & Amortization | 19.92M | 19.16M | 18.68M | 17.77M | 17.49M |
Other Operating Expenses | 243.00K | 269.00K | 42.35M | 83.00K | 47.00K |
Total Operating Expenses | 39.30M | 41.41M | 38.20M | 36.43M | 36.26M |
Operating Income | 52.89M | 48.30M | 47.55M | 46.51M | 48.94M |
Income Before Tax | 36.69M | 33.82M | 42.79M | 28.24M | 34.95M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 36.69M | 33.82M | 42.79M | 28.24M | 34.95M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 298.00K | 348.00K | 455.00K | 298.00K | 304.00K |
Net Income | 36.99M | 34.17M | 43.24M | 28.54M | 35.26M |
EBIT | 52.89M | 48.30M | 47.55M | 46.51M | 48.94M |
EBITDA | 72.81M | 67.46M | 66.23M | 64.28M | 66.43M |
EPS Basic | 0.79 | 0.75 | 0.96 | 0.66 | 0.81 |
Normalized Basic EPS | 0.50 | 0.47 | 0.46 | 0.46 | 0.50 |
EPS Diluted | 0.79 | 0.74 | 0.95 | 0.65 | 0.81 |
Normalized Diluted EPS | 0.49 | 0.47 | 0.45 | 0.46 | 0.50 |
Average Basic Shares Outstanding | 46.69M | 45.72M | 45.12M | 43.48M | 43.40M |
Average Diluted Shares Outstanding | 46.82M | 45.88M | 45.44M | 43.99M | 43.56M |
Dividend Per Share | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 |
Payout Ratio | 113.62% | 120.35% | 90.79% | 137.00% | 110.85% |